SG11202111838SA - Glp-1 secretion-promoting composition - Google Patents

Glp-1 secretion-promoting composition

Info

Publication number
SG11202111838SA
SG11202111838SA SG11202111838SA SG11202111838SA SG11202111838SA SG 11202111838S A SG11202111838S A SG 11202111838SA SG 11202111838S A SG11202111838S A SG 11202111838SA SG 11202111838S A SG11202111838S A SG 11202111838SA SG 11202111838S A SG11202111838S A SG 11202111838SA
Authority
SG
Singapore
Prior art keywords
glp
secretion
promoting composition
promoting
composition
Prior art date
Application number
SG11202111838SA
Inventor
Soichiro Urai
Koji Nagao
Yoshiaki Yokoo
Original Assignee
Suntory Holdings Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Holdings Ltd filed Critical Suntory Holdings Ltd
Publication of SG11202111838SA publication Critical patent/SG11202111838SA/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L2/00Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
    • A23L2/52Adding ingredients
    • A23L2/60Sweeteners
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0087Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
SG11202111838SA 2019-04-26 2020-04-22 Glp-1 secretion-promoting composition SG11202111838SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019086870 2019-04-26
PCT/JP2020/017400 WO2020218380A1 (en) 2019-04-26 2020-04-22 Glp-1 secretion-promoting composition

Publications (1)

Publication Number Publication Date
SG11202111838SA true SG11202111838SA (en) 2021-11-29

Family

ID=72941890

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202111838SA SG11202111838SA (en) 2019-04-26 2020-04-22 Glp-1 secretion-promoting composition

Country Status (8)

Country Link
US (1) US20220226354A1 (en)
EP (1) EP3960202A4 (en)
JP (1) JP7450613B2 (en)
CN (1) CN113747922A (en)
AU (1) AU2020263748A1 (en)
SG (1) SG11202111838SA (en)
TW (1) TWI796560B (en)
WO (1) WO2020218380A1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20230346849A1 (en) * 2022-04-29 2023-11-02 Teresa Bono Appetite Suppressant and Method of Use

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0710338B2 (en) * 1987-12-28 1995-02-08 有限会社野々川商事 Oil-in-water emulsion composition and polyhydric alcohol-in-oil emulsion composition
MXPA04012394A (en) * 2002-07-01 2005-02-25 Unilever Nv Satiety inducing composition.
JP2009517464A (en) * 2005-11-30 2009-04-30 カンピーナ ネーダーランド ホールディング ビー.ブイ. Use of protein hydrolysates that enhance the activity of glucagon-like peptide 1
JP2011046668A (en) * 2009-08-28 2011-03-10 Nof Corp Regulator for sustained secretion of glp-1 and insulin
EA033067B1 (en) * 2012-01-06 2019-08-30 Элселикс Терапьютикс, Инк. Method for treating metabolic disorders in a patient having a contraindication for a biguanide compound
JP2015047080A (en) * 2013-08-30 2015-03-16 株式会社ファンケル Emulsion composition
WO2015127297A1 (en) * 2014-02-21 2015-08-27 James and Carol May Family, LLLP Compositions and methods for the solubilization of stevia glycosides
US20180110823A1 (en) * 2015-04-22 2018-04-26 Cedars-Sinai Medical Center Enterically delivered bitter oligopeptides for the treatment for type 2 diabetes
JP6777632B2 (en) * 2015-07-27 2020-10-28 サントリーホールディングス株式会社 Compositions containing cyclic dipeptides and sweeteners
JP6802256B2 (en) 2016-03-16 2020-12-16 サントリーホールディングス株式会社 GLP-1 secretion promoting composition and method for producing the same
US20190381128A1 (en) * 2017-03-03 2019-12-19 Morinaga Milk Industry Co., Ltd. GLP-1 Secretagogue and Composition
US20220211731A1 (en) * 2019-04-26 2022-07-07 Suntory Holdings Limited Composition for promoting glp-1 secretion

Also Published As

Publication number Publication date
TW202106307A (en) 2021-02-16
JPWO2020218380A1 (en) 2020-10-29
WO2020218380A1 (en) 2020-10-29
CN113747922A (en) 2021-12-03
EP3960202A4 (en) 2023-01-18
AU2020263748A1 (en) 2021-12-02
JP7450613B2 (en) 2024-03-15
TWI796560B (en) 2023-03-21
US20220226354A1 (en) 2022-07-21
EP3960202A1 (en) 2022-03-02

Similar Documents

Publication Publication Date Title
GB201903287D0 (en) Composition
GB201913593D0 (en) Composition
GB201912061D0 (en) Composition
SG11202111838SA (en) Glp-1 secretion-promoting composition
GB201917899D0 (en) New composition
GB202002865D0 (en) Composition
GB201917565D0 (en) Composition
GB201916374D0 (en) Composition
GB2581344B (en) Novel composition
GB201911694D0 (en) Composition
GB201911454D0 (en) Composition
GB201907225D0 (en) Composition
GB201903340D0 (en) Composition
GB2581132B (en) Novel composition
GB201911581D0 (en) Novel composition
GB201911461D0 (en) Novel composition
GB202006445D0 (en) Composition
GB201910020D0 (en) Novel composition
GB201909264D0 (en) Novel composition
GB202004080D0 (en) Composition
GB202003848D0 (en) Composition
GB201902276D0 (en) New composition
GB201919296D0 (en) Composition
GB201919222D0 (en) Composition
GB201918997D0 (en) Composition